Stratec (ETR:SBS) Trading Down 3% – Time to Sell?

Stratec SE (ETR:SBSGet Free Report)’s share price traded down 3% on Thursday . The company traded as low as €35.90 ($39.02) and last traded at €35.90 ($39.02). 2,216 shares were traded during trading, a decline of 65% from the average session volume of 6,253 shares. The stock had previously closed at €37.00 ($40.22).

Stratec Stock Performance

The business has a fifty day simple moving average of €41.66 and a two-hundred day simple moving average of €42.87. The company has a debt-to-equity ratio of 65.99, a current ratio of 2.47 and a quick ratio of 1.65. The company has a market cap of $414.05 million, a PE ratio of 28.61, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Read More

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.